Scar formation following skin injury can be a major psychosocial and physiological problem. However, the mechanisms of scar formation are still not completely understood. Previous studies have shown that wound healing in oral mucosa is faster, associates with a reduced inflammatory response and results to significantly reduced scar formation compared with skin wounds. In the present study, we hypothesized that oral mucosal fibroblasts from human gingiva are inherently distinct from fibroblasts from breast and abdominal skin, two areas prone to excessive scar formation, which may contribute to the preferential wound healing outcome in gingiva. To this end, we compared the phenotype of human gingival and skin fibroblasts cultured in in vivo-like three-dimensional (3D) cultures that mimic the cells' natural extracellular matrix (ECM) niche. To establish 3D cultures, five parallel fibroblast lines from human gingiva (GFBLs) and breast skin (SFBLs) were seeded in high density, and cultured for up to 21 days in serum and ascorbic acid containing medium to induce expression of wound-healing transcriptome and ECM deposition. Cell proliferation, morphology, phenotype and expression of wound healing and scar related genes were analyzed by real-time RT-PCR, Western blotting and immunocytochemical methods. The expression of a set of genes was also studied in three parallel lines of human abdominal SFBLs. Findings showed that GFBLs displayed morphologically distinct organization of the 3D cultures and proliferated faster than SFBLs. GFBLs expressed elevated levels of molecules involved in regulation of inflammation and ECM remodeling (MMPs) while SFBLs showed significantly higher expression of TGF-β signaling, ECM and myofibroblast and cell contractility-related genes. Thus, GFBLs display an inherent phenotype conducive for fast resolution of inflammation and ECM remodeling, characteristic for scar-free wound healing, while SFBLs have a profibrotic, scar-prone phenotype.
References
[1]
Durani P, Occleston N, O'Kane S, Ferguson MW (2008) Avotermin: a novel antiscarring agent. Int J Low Extrem Wounds 7: 160–168. doi: 10.1177/1534734608322983
[2]
Gauglitz GG, Korting HC, Pavicic T, Ruzicka T, Jeschke MG (2011) Hypertrophic scarring and keloids: pathomechanisms and current and emerging treatment strategies. Mol Med 17: 113–125.
[3]
Penn JW, Grobbelaar AO, Rolfe KJ (2012) The role of the TGF-β family in wound healing, burns and scarring: a review. Int J Burns Trauma 2: 18–28.
[4]
Dobaczewski M, de Haan JJ, Frangogiannis NG (2012) The extracellular matrix modulates fibroblast phenotype and function in the infarcted myocardium. J Cardiovasc Transl Res 5: 837–847. doi: 10.1007/s12265-012-9406-3
[5]
Glim JE, van Egmond M, Niessen FB, Everts V, Beelen RH (2013) Detrimental dermal wound healing: What can we learn from the oral mucosa? Wound Repair Regen 21: 648–660. doi: 10.1111/wrr.12072
[6]
Wang J, Dodd C, Shankowsky HA, Scott PG, Tredget EE (2008) Deep dermal fibroblasts contribute to hypertrophic scarring. Lab Invest 88: 1278–1290. doi: 10.1038/labinvest.2008.101
[7]
Sarrazy V, Billet F, Micallef L, Coulomb B, Desmoulière A (2011) Mechanisms of pathological scarring: role of myofibroblasts and current developments. Wound Repair Regen 19: s10–15. doi: 10.1111/j.1524-475x.2011.00708.x
[8]
Sciubba JJ, Waterhouse JP, Meyer J (1978) A fine structural comparison of the healing of incisional wounds of mucosa and skin. J Oral Pathol 7: 214–227. doi: 10.1111/j.1600-0714.1978.tb01596.x
[9]
Szpaderska AM, Zuckerman JD, DiPietro LA (2003) Differential injury responses in oral mucosal and cutaneous wounds. J Dent Res 82: 621–626. doi: 10.1177/154405910308200810
[10]
Mak K, Manji A, Gallant-Behm C, Wiebe C, Hart DA, et al. (2009) Scarless healing of oral mucosa is characterized by faster resolution of inflammation and control of myofibroblast action compared to skin wounds in the red Duroc pig model. J Dermatol Sci 56: 168–180. doi: 10.1016/j.jdermsci.2009.09.005
[11]
Fournier BP, Larjava H, H？kkinen L (2013) Gingiva as a Source of Stem Cells with Therapeutic Potential. Stem Cells Dev 22: 3157–3177. doi: 10.1089/scd.2013.0015
[12]
Schor SL, Ellis I, Irwin CR, Banyard J, Seneviratne K, et al. (1996) Subpopulations of fetal-like gingival fibroblasts: characterisation and potential significance for wound healing and the progression of periodontal disease. Oral Dis 2: 155–166. doi: 10.1111/j.1601-0825.1996.tb00217.x
[13]
Chang HY, Chi JT, Dudoit S, Bondre C, van de Rijn M, et al. (2002) Diversity, topographic differentiation, and positional memory in human fibroblasts. Proc Natl Acad Sci U S A 99: 12877–122882. doi: 10.1073/pnas.162488599
[14]
Rinn JL, Bondre C, Gladstone HB, Brown PO, Chang HY (2006) Anatomic demarcation by positional variation in fibroblast gene expression programs. PLoS Genet 2: e119. doi: 10.1371/journal.pgen.0020119
[15]
Rinn JL, Wang JK, Liu H, Montgomery K, van de Rijn M, et al. (2008) A systems biology approach to anatomic diversity of skin. J Invest Dermatol 128: 776–782. doi: 10.1038/sj.jid.5700986
[16]
Ebisawa K, Kato R, Okada M, Sugimura T, Latif MA, et al. (2011) Gingival and dermal fibroblasts: their similarities and differences revealed from gene expression. J Biosci Bioeng 111: 255–258. doi: 10.1016/j.jbiosc.2010.11.014
[17]
Xu X, Chen C, Akiyama K, Chai Y, Le AD, et al. (2013) Gingivae contain neural-crest- and mesoderm-derived mesenchymal stem cells. J Dent Res 92: 825–832. doi: 10.1177/0022034513497961
[18]
Cukierman E, Pankov R, Stevens DR, Yamada KM (2001) Taking cell-matrix adhesions to the third dimension. Science 294: 1708–1712. doi: 10.1126/science.1064829
[19]
Green JA, Yamada KM (2007) Three-dimensional microenvironments modulate fibroblast signaling responses. Adv Drug Deliv Rev 59: 1293–1298. doi: 10.1016/j.addr.2007.08.005
[20]
Pouyani T, Papp S, Schaffer L (2012) Tissue-engineered fetal dermal matrices. In Vitro Cell Dev Biol Anim 48: 493–506. doi: 10.1007/s11626-012-9541-9
[21]
Quiros RM, Valianou M, Kwon Y, Brown KM, Godwin AK, et al. (2008) Ovarian normal and tumor-associated fibroblasts retain in vivo stromal characteristics in a 3-D matrix-dependent manner. GYNECOL ONCOL 110: 99–109. doi: 10.1016/j.ygyno.2008.03.006
[22]
Lai Y, Sun Y, Skinner CM, Son EL, Lu Z, et al. (2010) Reconstitution of marrow-derived extracellular matrix ex vivo: a robust culture system for expanding large-scale highly functional human mesenchymal stem cells. Stem Cells Dev 19: 1095–1107. doi: 10.1089/scd.2009.0217
[23]
Gangemi EN, Gregori D, Berchialla P, Zingarelli E, Cairo M, et al. (2008) Epidemiology and risk factors for pathologic scarring after burn wounds. Arch Facial Plast Surg 10: 93–102. doi: 10.1001/archfaci.10.2.93
[24]
Mahdavian Delavary B, van der Veer WM, Ferreira JA, Niessen FB (2012) Formation of hypertrophic scars: evolution and susceptibility. J Plast Surg Hand Surg 46: 95–101. doi: 10.3109/2000656x.2012.669184
[25]
H？kkinen L, Heino J, Koivisto L, Larjava H (1994) Altered interaction of human granulation-tissue fibroblasts with fibronectin is regulated by alpha 5 beta 1 integrin. Biochim Biophys Acta 1224: 33–42. doi: 10.1016/0167-4889(94)90110-4
[26]
Beacham DA, Amatangelo MD, Cukierman E (2007) Preparation of extracellular matrices produced by cultured and primary fibroblasts. Curr Protoc Cell Biol, Chapter 10:Unit 10.9. doi: 10.1002/0471143030.cb1009s33
[27]
King SJ, Parsons M (2011) Imaging cells within 3D cell-derived matrix. Methods Mol Biol 769: 53–64. doi: 10.1007/978-1-61779-207-6_5
[28]
Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, et al. (2002) Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 18 3: RESEARCH0034.
[29]
Nagase H, Suzuki K, Enghild JJ, Salvesen G (1991) Stepwise activation mechanisms of the precursors of matrix metalloproteinases 1 (tissue collagenase) and 3 (stromelysin). Biomed Biochim Acta 50: 749–754.
[30]
Badri KR, Yue M, Carretero OA, Aramgam SL, Cao J, et al. (2013) Blood pressure homeostasis is maintained by a P311-TGF-β axis. J Clin Invest 123: 4502–4512. doi: 10.1172/jci69884
[31]
Fang F, Ooka K, Bhattacharyya S, Wei J, Wu M, et al. (2011) The early growth response gene Egr2 (Alias Krox20) is a novel transcriptional target of transforming growth factor-β that is up-regulated in systemic sclerosis and mediates profibrotic responses. Am J Pathol 178: 2077–2090. doi: 10.1016/j.ajpath.2011.01.035
[32]
Bhattacharyya S, Fang F, Tourtellotte W, Varga J (2013) Egr-1: new conductor for the tissue repair orchestra directs harmony (regeneration) or cacophony (fibrosis). J PATHOL 229: 286–297. doi: 10.1002/path.4131
[33]
Fang F, Shangguan AJ, Kelly K, Wei J, Gruner K, et al. (2013) Early Growth Response 3 (Egr-3) Is Induced by Transforming Growth Factor-β and Regulates Fibrogenic Responses. Am J Pathol 183: 1197–1208. doi: 10.1016/j.ajpath.2013.06.016
[34]
Braddock M, Campbell CJ, Houston P (2000) Therapeutic applications of the transcriptional corepressor proteins NAB1 and NAB2 in regenerative medicine. IDrugs 3: 783–787.
[35]
Lan HY, Chung AC (2012) TGF-β/Smad signaling in kidney disease. Semin Nephrol 32: 236–243. doi: 10.1016/j.semnephrol.2012.04.002
[36]
LeClair R, Lindner V (2007) The role of collagen triple helix repeat containing 1 in injured arteries, collagen expression, and transforming growth factor beta signaling. Trends Cardiovasc Med 17: 202–205. doi: 10.1016/j.tcm.2007.05.004
[37]
Li J, Cao J, Li M, Yu Y, Yang Y, et al. (2011) Collagen triple helix repeat containing-1 inhibits transforming growth factor-b1-induced collagen type I expression in keloid. Br J Dermatol 164: 1030–6. doi: 10.1111/j.1365-2133.2011.10215.x
[38]
Liakouli V, Cipriani P, Marrelli A, Alvaro S, Ruscitti P, et al. (2011) Angiogenic cytokines and growth factors in systemic sclerosis. Autoimmun Rev 10: 590–594. doi: 10.1016/j.autrev.2011.04.019
[39]
Johnson A, Dipietro LA (2013) Apoptosis and angiogenesis: an evolving mechanism for fibrosis. FASEB J 27: 3893–3901. doi: 10.1096/fj.12-214189
[40]
Bond JE, Ho TQ, Selim MA, Hunter CL, Bowers EV, et al. (2011) Temporal spatial expression and function of non-muscle myosin II isoforms IIA and IIB in scar remodeling. Lab Invest 91: 499–508. doi: 10.1038/labinvest.2010.181
[41]
Carracedo S, Lu N, Popova SN, Jonsson R, Eckes B, et al. (2011) The fibroblast integrin alpha11beta1 is induced in a mechanosensitive manner involving activin A and regulates myofibroblast differentiation. J Biol Chem 285: 10434–10445. doi: 10.1074/jbc.m109.078766
[42]
Ehrlich HP, Allison GM, Leggett M (2006) The myofibroblast, cadherin, alpha smooth muscle actin and the collagen effect. Cell Biochem Funct 24: 63–70. doi: 10.1002/cbf.1188
[43]
Lam AP, Gottardi CJ (2011) β-catenin signaling: a novel mediator of fibrosis and potential therapeutic target. Curr Opin Rheumatol 23: 562–567. doi: 10.1097/bor.0b013e32834b3309
[44]
Nakerakanti S, Trojanowska M (2012) The Role of TGF-β Receptors in Fibrosis. Open Rheumatol J 6: 156–162. doi: 10.2174/1874312901206010156
[45]
Adams PD (2009) Healing and hurting: molecular mechanisms, functions, and pathologies of cellular senescence. Mol Cell 36: 2–14. doi: 10.1016/j.molcel.2009.09.021
[46]
Wong JW, Gallant-Behm C, Wiebe C, Mak K, Hart DA, et al. (2009) Wound healing in oral mucosa results in reduced scar formation as compared with skin: evidence from the red Duroc pig model and humans. Wound Repair Regen 17: 717–729. doi: 10.1111/j.1524-475x.2009.00531.x
[47]
Iyer VR, Eisen MB, Ross DT, Schuler G, Moore T, et al. (1999) The transcriptional program in the response of human fibroblasts to serum. Science 283: 83–87. doi: 10.1126/science.283.5398.83
[48]
Jun JI, Lau LF (2010) Cellular senescence controls fibrosis in wound healing. Aging (Albany NY) 2: 627–631.
[49]
Pitiyage GN, Slijepcevic P, Gabrani A, Chianea YG, Lim KP, et al. (2011) Senescent mesenchymal cells accumulate in human fibrosis by a telomere-independent mechanism and ameliorate fibrosis through matrix metalloproteinases. J Pathol 223: 604–617. doi: 10.1002/path.2839
[50]
Bradshaw AD, Sage EH (2001) SPARC, a matricellular protein that functions in cellular differentiation and tissue response to injury. J Clin Invest 107: 1049–1054. doi: 10.1172/jci12939
[51]
Mori R, Shaw TJ, Martin P (2008) Molecular mechanisms linking wound inflammation and fibrosis: knockdown of osteopontin leads to rapid repair and reduced scarring. J Exp Med 205: 43–51. doi: 10.1084/jem.20071412
[52]
Kyriakides TR, Maclauchlan S (2009) The role of thrombospondins in wound healing, ischemia, and the foreign body reaction. J Cell Commun Signal 3: 215–225. doi: 10.1007/s12079-009-0077-z
[53]
Oliveira GV, Hawkins HK, Chinkes D, Burke A, Tavares AL, et al. (2009) Hypertrophic versus non hypertrophic scars compared by immunohistochemistry and laser confocal microscopy: type I and III collagens. Int Wound J 6: 445–452. doi: 10.1111/j.1742-481x.2009.00638.x
[54]
H？kkinen L, Larjava H, Koivisto L (2012) Granulation Tissue Formation and Remodeling. Endodontic Topics 24: 94–129. doi: 10.1111/etp.12008
[55]
Mikesh LM, Aramadhaka LR, Moskaluk C, Zigrino P, Mauch C, et al. (2013) Proteomic anatomy of human skin. J Proteomics 84: 190–200. doi: 10.1016/j.jprot.2013.03.019
[56]
Iozzo RV, Schaefer L (2010) Proteoglycans in health and disease: novel regulatory signaling mechanisms evoked by the small leucine-rich proteoglycans. FEBS J 277: 3864–3875. doi: 10.1111/j.1742-4658.2010.07797.x
[57]
Frey H, Schroeder N, Manon-Jensen T, Iozzo RV, Schaefer L (2013) Biological interplay between proteoglycans and their innate immune receptors in inflammation. FEBS J 280: 2165–2179. doi: 10.1111/febs.12145
[58]
Bhide VM, Laschinger CA, Arora PD, Lee W, H？kkinen L, et al. (2005) Collagen phagocytosis by fibroblasts is regulated by decorin. J Biol Chem 280: 23103–23113. doi: 10.1074/jbc.m410060200
[59]
Soo C, Hu FY, Zhang X, Wang Y, Beanes SR, et al. (2000) Differential expression of fibromodulin, a transforming growth factor-beta modulator, in fetal skin development and scarless repair. Am J Pathol 157: 423–433. doi: 10.1016/s0002-9440(10)64555-5
[60]
Honardoust D, Eslami A, Larjava H, H？kkinen L (2008) Localization of small leucine-rich proteoglycans and transforming growth factor-beta in human oral mucosal wound healing. Wound Repair Regen 16: 814–823. doi: 10.1111/j.1524-475x.2008.00435.x
[61]
Honardoust D, Varkey M, Hori K, Ding J, Shankowsky HA, et al. (2011) Small leucine-rich proteoglycans, decorin and fibromodulin, are reduced in postburn hypertrophic scar. Wound Repair Regen 19: 368–378. doi: 10.1111/j.1524-475x.2011.00677.x
[62]
Mann J, Mann DA (2013) Epigenetic regulation of wound healing and fibrosis. Curr Opin Rheumatol 25: 101–107. doi: 10.1097/bor.0b013e32835b13e1
[63]
L？ffek S, Schilling O, Franzke CW (2011) Series “matrix metalloproteinases in lung health and disease”: Biological role of matrix metalloproteinases: a critical balance. Eur Respir J 38: 191–208. doi: 10.1183/09031936.00146510
[64]
Dufour A, Overall CM (2013) Missing the target: matrix metalloproteinase antitargets in inflammation and cancer. Trends Pharmacol Sci 34: 233–242. doi: 10.1016/j.tips.2013.02.004
[65]
Eba H, Murasawa Y, Iohara K, Isogai Z, Nakamura H, et al. (2012) The anti-inflammatory effects of matrix metalloproteinase-3 on irreversible pulpitis of mature erupted teeth. PLoS One 7: e52523. doi: 10.1371/journal.pone.0052523
[66]
Tocchi A, Parks WC (2013) Functional interactions between matrix metalloproteinases and glycosaminoglycans. FEBS J 280: 2332–2341. doi: 10.1111/febs.12198
[67]
Dang CM, Beanes SR, Lee H, Zhang X, Soo C, et al. (2003) Scarless fetal wounds are associated with an increased matrix metalloproteinase-to-tissue-derived inhibitor of metalloproteinase ratio. Plast Reconstr Surg 111: 2273–2285. doi: 10.1097/01.prs.0000060102.57809.da
[68]
McKeown ST, Barnes JJ, Hyland PL, Lundy FT, Fray MJ, et al. (2007) Matrix metalloproteinase-3 differences in oral and skin fibroblasts. J Dent Res 86: 457–462. doi: 10.1177/154405910708600513
[69]
Horiguchi M, Ota M, Rifkin DB (2012) Matrix control of transforming growth factor-β function. J Biochem 152: 321–329. doi: 10.1093/jb/mvs089
[70]
Schiavinato A, Becker AK, Zanetti M, Corallo D, Milanetto M, et al. (2012) EMILIN-3, peculiar member of elastin microfibril interface-located protein (EMILIN) family, has distinct expression pattern, forms oligomeric assemblies, and serves as transforming growth factor β (TGF-β) antagonist. J Biol Chem 287: 11498–11515. doi: 10.1074/jbc.m111.303578
[71]
Chen YG (2009) Endocytic regulation of TGF-beta signaling. Cell Res 19: 58–70. doi: 10.1038/cr.2008.315
[72]
Guo F, Carter DE, Leask A (2011) Mechanical tension increases CCN2/CTGF expression and proliferation in gingival fibroblasts via a TGFβ-dependent mechanism. PLoS One 6: e19756. doi: 10.1371/journal.pone.0019756
[73]
Wipff PJ, Hinz B (2008) Integrins and the activation of latent transforming growth factor beta1 - an intimate relationship. Eur J Cell Biol 87: 601–615. doi: 10.1016/j.ejcb.2008.01.012
[74]
Yang Z, Mu Z, Dabovic B, Jurukovski V, Yu D, et al. (2007) Absence of integrin-mediated TGFbeta1 activation in vivo recapitulates the phenotype of TGFbeta1-null mice. J Cell Biol 176: 787–793. doi: 10.1083/jcb.200611044
